Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables 麻豆原创 and Increasing Usage of Complex Biologics during the Forecast Period

You are here: 麻豆原创 Catalog Pharma & Healthcare Generic Drugs Finance & Investment (Pharma & Healthcare)

Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables 麻豆原创 and Increasing Usage of Complex Biologics during the Forecast Period

麻豆原创 Research Report Summary

Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables 麻豆原创 and Increasing Usage of Complex Biologics during the Forecast Period report is published on November 1, 2016 and has 73 pages in it. This market research report provides information about Generic Drugs, Finance & Investment (Pharma & Healthcare), Pharma & Healthcare industry. It covers Global market data and forecasts. It is priced starting at USD 2,995.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables 麻豆原创 and Increasing Usage of Complex Biologics during the Forecast Period

Printer version

Send by email

Publication ID:听

CBR1116001

Publication Date:听

November 1, 2016

笔补驳别蝉:听

73

笔耻产濒颈蝉丑别谤:听

CBR Pharma Insights

颁辞耻苍迟谤颈别蝉:听

Global

USD 2,995.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables 麻豆原创 and Increasing Usage of Complex Biologics during the Forecast Period

Summary

GBI Research鈥檚 latest report, "Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables 麻豆原创 and Increasing Usage of Complex Biologics during the Forecast Period" discusses the drug delivery technologies and trends in the market and the evolving business strategies being adopted and leveraged by companies globally. The ultimate goal of drug delivery research is to develop formulations and devices that can be used in clinical applications to treat various diseases. Delivering a drug with the desired release kinetics requires an understanding of the underlying physicochemical properties of the drug, which determine the type of delivery material and drug release mechanism. Numerous parameters need to be considered, and their inter-dependence has to be taken into account to develop successful drug delivery systems for the intended applications. It is important to understand the complexity associated with the development of a drug delivery system that can ultimately be used in human patients. The report covers the currently available drug delivery technologies and recent advances in the field, with granular analyses of the different types of delivery systems, their advantages, disadvantages and opportunities for future development. The report provides global market forecasts by revenue for the market until 2020. Additionally, forecasts by revenue for key geographical markets and supporting analyses of the main factors driving or restraining growth are included. The market for drug delivery technology is poised for strong growth in the coming years. Key factors promoting growth include the rapidly expanding injectables market, the growing incidence of chronic diseases and the expected significant increase in the use of complex biologic drugs that necessitate novel delivery systems. Drug delivery companies have had to adapt to challenging times in the same way as pharmaceutical companies have had to over the past decade. These companies have achieved this by adopting new business strategies that allow them to take better control of their commercial and financial future. The report analyzes how business models in this dynamic industry have evolved over the last couple of decades and how new companies with improved product portfolios and propositions are emerging.

Scope

- What are the drug delivery technologies used in the market and how have they evolved in recent years?
- What will be the market value, by revenue, of the market over the coming years?
Drivers and restraints in the drug delivery industry:
- What are the most important factors promoting growth in the market at a global level?
- What are the most important factors restraining growth in the market?
- What is the impact of novel delivery systems on the management of a product鈥檚 lifecycle?
- Will emerging markets contribute significantly to the growth of the global market?
- How will regulatory- and reimbursement-related challenges hinder the market?
Technologies based on drug vehicle/carriers:
- What are the various advantages, limitations and applications of the currently available drug carriers?
Technologies based on route of administration:
- How can lifecycle management strategies reposition existing drugs by changing their route of administration?
- What are the advantages, limitations and applications of the different drug delivery technologies, based on their route of administration?
- What are the prospects for revenue growth for the latest technologies, including metered-dose inhalers and hydrogels?
Technologies for injectables:
- Which technologies in the injectables market have contributed to overall growth?
- What is the market forecast for needle-free injectors in the coming years?
- What is driving the need for novel delivery systems for injectable drugs?

Reasons to buy

- Gain insightful analyses and understanding of market dynamics. The report comprehensively describes and assesses the most important factors driving and restraining the drug delivery technology market.
- Evaluate a granular assessment of the pipelines for the various drug delivery technology segments and the prospects and revenue forecasts for the upcoming delivery technologies until 2020.
- Evaluate the strategies and business models used by companies to achieve their full commercial potential.
- Gain insight on upcoming trends and factors influencing the global market for drug delivery technology.

Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 4
1.2 List of Figures 4
2 Drug Delivery Technologies - An Overview 5
2.1 Drug Delivery Research: Past and Present 5
2.2 Drug Delivery Technologies 麻豆原创, 2006-2020 6
2.2.1 Drug Delivery Technologies 麻豆原创: Key Geographical 麻豆原创s, 2010-2020 7
2.3 Drug Delivery Technologies 麻豆原创: Drivers and Restraints in 2016 8
2.3.1 Key Factors Promoting Growth in Drug Delivery Technologies 麻豆原创 8
2.3.2 Key Factors Restraining Growth in the Drug Delivery Technologies 麻豆原创 10
3 Current Drug Delivery Technologies and Recent Developments 12
3.1 Technologies Based on Drug Vehicle or Carrier 12
3.1.1 Lipid-Based Drug Carriers by Type 12
3.1.2 Polymer-Based Drug Delivery 15
3.1.3 Cell-Based Drug Delivery Systems 16
3.1.4 Magnetic Particle Drug Delivery 18
3.1.5 Nucleic Acid-Based Drug Delivery 20
3.2 Technologies Based on Route of Administration 22
3.2.1 Nasal and Pulmonary Drug Delivery 23
3.2.2 Ocular Drug Delivery 27
3.2.3 Topical Drug Delivery 29
3.2.4 Oral Drug Delivery 33
3.2.5 Implantable Drug Delivery 35
3.2.6 Transdermal Drug Delivery Technology 38
3.2.7 Parenteral Drug Delivery 41
4 Advances in Injectable Drug Delivery 麻豆原创 43
4.1 Self-injection Devices 43
4.1.1 Pen Injectors 43
4.1.2 Auto-Injectors 46
4.2 Pre-filled Syringes 50
4.2.1 Glass Pre-filled Syringes 51
4.2.2 Plastic/Polymer Pre-filled Syringes 52
4.2.3 Pre-filled Safety Syringes 52
4.3 Recent Developments 55
4.3.1 Microneedles 55
4.3.2 Needle-Free Injection Devices 58
4.3.3 Needle-Free Devices 麻豆原创, 2006-2020 61
5 Evolving Business Models in the Drug Delivery Technologies 麻豆原创 63
6 Future Outlook for Drug Delivery Technologies 65
7 Bibliography 66
8 Appendix 70
8.1 Drug Delivery Technology 麻豆原创, 麻豆原创 Value ($m), 2006-2020 70
8.2 Drug Delivery Technology 麻豆原创, 麻豆原创 Value by Country ($m), 2010-2020 70
8.3 Metered-Dose Inhaler 麻豆原创 ($bn), 2006-2020 71
8.4 Hydrogels, Wound Management 麻豆原创 ($m), 2006-2020 71
8.5 Repatha, Annual Sales ($m), 2016-2021 72
8.6 Needle-Free Injectables, Global 麻豆原创 Forecast ($m), 2006-2020 72
8.7 Contact Us 73
8.8 Disclaimer 73

1.1 List of Tables
Table 1: Lipid Formulation Classification System 14
Table 2: Polymer-Based Drug Delivery Systems 16
Table 3: Cell-Based Biological Carriers Used for Drug- or Gene-Delivery Systems 17
Table 4: Cell-Based Biological Carriers Used in Drug- or Gene-Delivery Systems 18
Table 5: Therapeutic Molecules Loaded Within or Conjugated to DNA Nanocarriers 20
Table 6: Notable Therapies with Drug Delivery Systems 22
Table 7: Selected Metered-Dose Inhalers in Development 26
Table 8: Selected Intranasal Vaccines in Development 27
Table 9: Selected List of Contact Lens Drug Delivery Devices in Development 29
Table 10: Topical-Based Drug Delivery Technologies 31
Table 11: Topical Drug Delivery Pipeline 32
Table 12: Oral Drug Delivery 麻豆原创 Segments 34
Table 13: Oral Drug Delivery Pipeline 35
Table 14: Implantable Drug Delivery 麻豆原创 Segments 36
Table 15: Implantable Drug Delivery Pipeline 37
Table 16: Transdermal Drug Delivery 38
Table 17: Transdermal Drug Delivery Segmentation 39
Table 18: Transdermal Drug Delivery Pipeline 40
Table 19: Pen Injectors by Type 44
Table 20: Auto-injectors by Type 46
Table 21: Key 麻豆原创ed Auto-injector Products 47
Table 22: Key Auto-injector Products in Development 50
Table 23: Pre-filled Syringes by Type 51
Table 24: Needle-Free Injectors by Types, Categories, Products and Examples 59
Table 25: Needle-Free Injectors, 麻豆原创ed Products by Company 60
Table 26: Needle-Free Injectors, Pipeline Products by Company 61

1.2 List of Figures
Figure 1: Common Types of Drug Delivery Carriers 5
Figure 2: Drug Delivery Technology 麻豆原创, 麻豆原创 Value ($m), 2006-2020 7
Figure 3: Drug Delivery Technology 麻豆原创, 麻豆原创 Value by Country ($m), 2010-2020 8
Figure 4: Types of Lipid-Based Drug Delivery Systems 13
Figure 5: Polymer-Based Drug Delivery Technology, Polymer Categories 15
Figure 6: Magnetic Particle Drug Delivery by Type and Applications 19
Figure 7: Nasal and Pulmonary Drug Deliveries by Type 24
Figure 8: Metered-Dose Inhaler 麻豆原创 ($bn), 2006-2020 25
Figure 9: Ocular Drug Delivery Technology Segmentation 28
Figure 10: Topical Drug Delivery, Major Drug Classes in Topical Dosage Form 30
Figure 11: Hydrogels, Wound Management 麻豆原创 ($m), 2006-2020 32
Figure 12: Repatha, Annual Sales ($m), 2016-2021 49
Figure 13: Microneedles by Type 56
Figure 14: Needle-Free Injectables, Global 麻豆原创 Forecast ($m), 2006-2020 62
Figure 15: Evolving Business Models in the Drug Delivery Technologies 麻豆原创, 1980-2016 64
Figure 16: Drug Delivery Technology 麻豆原创, 麻豆原创 Value ($m), 2006-2020 70
Figure 17: Drug Delivery Technology 麻豆原创, 麻豆原创 Value by Country ($m), 2010-2020 70
Figure 18: Metered-Dose Inhaler 麻豆原创 ($bn), 2006-2020 71
Figure 19: Hydrogels, Wound Management 麻豆原创 ($m), 2006-2020 71
Figure 20: Repatha, Annual Sales ($m), 2016-2021 72
Figure 21: Needle-Free Injectables, Global 麻豆原创 Forecast ($m), 2006-2020 72

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Generic Drugs

Finance & Investment (Pharma & Healthcare)

Pharma & Healthcare

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
North America (NAFTA) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 North America (NAFTA) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Summary The NAFTA Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The generics industry within the NAFTA countries had a total market value of $82,183.1 million in 2022.The Canada was the fastest growing country, with a CAGR of 4.7% over the 2018-22 period. - Within the generics industry, the US is the leading country among the NAFTA bloc, with market revenues of $69,916.7 million in 2022. This was followed by Canada and Mexico, with a value of $6...Read more	USD 795.00
BRIC Countries (Brazil, Russia, India, China) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 BRIC Countries (Brazil, Russia, India, China) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Summary The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the generics industry and had a total market value of $144,339.7 million in 2022. China was the fastest growing country with a CAGR of 14.1% over the 2018-22 period. - Within the generics industry, China is the leading country among the BRIC nations with market revenues of $111,666.9 million in 2022. This was followed by India, Russia and Brazil with a value of $17,617.5, $11,917.6, and $3,137...Read more	USD 995.00
Top 5 Emerging Countries Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Top 5 Emerging Countries Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Summary The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - These countries contributed $139,492.2 million to the global generics industry in 2022, with a compound annual growth rate (CAGR) of 12.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $210,704.1 million in 2027, with a CAGR of 8.6% over the 2022-27 period. - Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $111,666.9 million in 2022. This was followed by India and Mexico with a value of $17,617.5 and $...Read more	USD 995.00
Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Summary Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. - 麻豆原创 volume is quantified here as the percentage of the total...Read more	USD 1,495.00
Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 (Global Almanac) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 (Global Almanac) Summary Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. - 麻豆原创 volume is quantified here as the...Read more	USD 2,995.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创